Inici › Càncer de pulmó › Ohio › Toledo
Assaigs clínics de Càncer de pulmó a Toledo, OH
11 estudis de Càncer de pulmó busquen participants en centres de Toledo i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutantFase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · a 8 mi
- ProMedica Flower Hospital, Sylvania · a 9 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Mercy Health - Saint Vincent Hospital, Toledo
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health Sylvania Radiation Oncology Center, Toledo
- i 1 més
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutantFase 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · a 8 mi
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ReclutantFase 3
- Taylor Cancer Research Center, Maumee · a 9 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutantFase 3
- Mercy Health - Perrysburg Hospital, Perrysburg · a 8 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutantFase 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · a 8 mi
- ProMedica Flower Hospital, Sylvania · a 9 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutantFase 1/2
- Taylor Cancer Research Center, Maumee · a 9 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutantFase 2
- ProMedica Flower Hospital, Sylvania · a 9 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutantFase 2/3
- ProMedica Flower Hospital, Sylvania · a 9 mi
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
ReclutantFase 1/2
- Taylor Cancer Research Center (site 204), Maumee · a 9 mi
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
ReclutantEstudi observacional
- Mercy Health St. Vincent Medical Center, Toledo
Assaigs de Càncer de pulmó en altres ciutats
- Houston, TX78 estudis
- Boston, MA62 estudis
- New York City, NY60 estudis
- Los Angeles, CA45 estudis
- Washington, DC41 estudis
- Arlington, VA41 estudis
- Chicago, IL41 estudis
- Nashville, TN40 estudis
- Baltimore, MD40 estudis
- St. Louis, MO39 estudis
- Columbus, OH37 estudis
- Philadelphia, PA36 estudis
Altres estudis a Toledo
- Càncer de pulmó de cèl·lules no petites17 estudis
- Càncer d'ovari12 estudis
- Càncer metastàtic10 estudis
- Ictus9 estudis
- Càncer d'endometri8 estudis
- Melanoma8 estudis
- Càncer de pàncrees8 estudis
- Carcinoma de cèl·lules escamoses de cap i coll8 estudis
- Càncer d'esòfag7 estudis
- Càncer de pròstata7 estudis
- Insuficiència cardíaca7 estudis
- Càncer colorrectal7 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.